Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced that it received a $3 million Phase IIB Small Business Innovation Research (SBIR) grant from the National Institutes of Health to use its EchoMark & EchoSure devices to support arteriovenous (AV) fistula maturation and long-term viability. The award provides capital for prospective clinical studies and continued research and development efforts.
{iframe}http://www.prweb.com/releases/nih_awards_sonavex_inc_3_million_grant_to_pursue_new_vascular_surgery_applications_for_echomark_echosure/prweb16529918.htm{/iframe}